Physician profile
Robert Michael Holtrup
NPI 1669604609
$3,844.67
in general payments reported to CMS, 2019-2025
35 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $167 · 2023: $273 · 2024: $1,590 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,456.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $852.59 | 2023-2025 | Breztri, Tezspire, Farxiga |
| Abbvie INC. | $584.78 | 2023-2025 | |
| Dexcom, INC. | $276.35 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $244.95 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $165.97 | 2021-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Amgen INC. | $157.94 | 2023-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $133.33 | 2024-2025 | |
| Glaxosmithkline, LLC. | $119.63 | 2021-2025 | Bexsero, Trelegy Ellipta, Pediarix |
| Pfizer INC. | $118.71 | 2021-2025 | |
| Exact Sciences Corporation | $112.77 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $110.37 | 2024 | Veozah |
| Cequr Corporation | $97.75 | 2024-2025 | Cequr Simplicity |
| Seqirus USA INC | $86.50 | 2021-2023 | Flucelvax Quadrivalent |
| Abbott Laboratories | $76.91 | 2023-2024 | Freestyle Libre 3 |
| Amphastar Pharmaceuticals, INC. | $71.69 | 2024-2025 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Holtrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.